Substance Use Archives - PsychPartners

Dosing Buprenorphine in the Fentanyl Era

Addiction Meds Disorders Medications Opioids Research Substance Use

Dosing Buprenorphine in the Fentanyl Era

August 3, 2026by Chris Aiken, MD2

How Naltrexone-Bupropion Treats Meth Use Disorder

Addiction Meds Depression Disorders Methamphetamine Research Substance Use

How Naltrexone-Bupropion Treats Meth Use Disorder

July 29, 2026by Chris Aiken, MD0

Oral Ozempic Delivers Mixed Results on Alcohol Use

Alcohol GLP1 Agonists Medications Research Substance Use

Oral Ozempic Delivers Mixed Results on Alcohol Use

July 29, 2026by Chris Aiken, MD0

Ketamine for Addiction

Addiction Meds Alcohol Cocaine Disorders Ketamine Medications Opioids Research Substance Use

Ketamine for Addiction

July 24, 2026by Chris Aiken, MD0

How to Personalize Meds for Alcohol Use Disorder

Addiction Meds Alcohol Disorders Med-Psych Research Substance Use

How to Personalize Meds for Alcohol Use Disorder

July 23, 2026by Chris Aiken, MD0

Buprenorphine vs Naltrexone: A Large Study

Addiction Meds Medications Opioids Research Substance Use

Buprenorphine vs Naltrexone: A Large Study

July 15, 2026by Chris Aiken, MD0

New Guidelines For Substance Use Disorders

Addiction Meds Alcohol Cannabis Disorders Methamphetamine Opioids Research Sedatives Substance Use

New Guidelines For Substance Use Disorders

July 12, 2026by Chris Aiken, MD2

Six Years in Prison for Over-prescribing Adderall

ADHD Disorders Medications Methamphetamine Research Stimulants Substance Use

Six Years in Prison for Over-prescribing Adderall

July 10, 2026by Chris Aiken, MD0

Addiction Meds Disorders Med-Psych Opioids Research Substance Use

Matching Opioid MAT for Complex Patients

July 10, 2026by Chris Aiken, MD0

How Fast Does the Brain Recover from Cannabis?

Cannabis Cognition Disorders Research Research for the Public Substance Use

How Fast Does the Brain Recover from Cannabis?

July 9, 2026by Chris Aiken, MD0

Buprenorphine and Naltrexone for Impaired Physicians

Alcohol Opioids Research Substance Use

Buprenorphine and Naltrexone for Impaired Physicians

June 17, 2026by Chris Aiken, MD0

Can GLP-1s Both Cause and Prevent Pancreatitis?

Alcohol GLP1 Agonists Med-Psych Research Research for the Public Side Effects Top Research

Can GLP-1s Both Cause and Prevent Pancreatitis?

June 15, 2026by Chris Aiken, MD1

Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal

Addiction Meds Alcohol Disorders Medications Research Substance Use

Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal

June 13, 2026by Chris Aiken, MD0

Stimulant Misuse Is Declining

ADHD Child Psychiatry Cocaine Medications Research Stimulants Substance Use

Stimulant Misuse Is Declining

June 9, 2026by Chris Aiken, MD0

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

Alcohol Medications Research Substance Use

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

June 9, 2026by Chris Aiken, MD0

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

Addiction Meds Cocaine Medications Methamphetamine Research Substance Use Top Research

One Med Stands Out in Re-Analysis of Cocaine Use Disorder

June 8, 2026by Chris Aiken, MD0

FDA Moves the Goalposts on Alcohol Treatment

Addiction Meds Alcohol Research Substance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0

New Guidelines for Psychosis Prevention

Cannabis Child Psychiatry Disorders Research Schizophrenia and Psychosis Substance Use Therapy

New Guidelines for Psychosis Prevention

May 28, 2026by Chris Aiken, MD0

Does Buprenorphine Block Opioid Overdose?

Benzodiazepines Opioids Research Substance Use

Does Buprenorphine Block Opioid Overdose?

May 27, 2026by Chris Aiken, MD0

Cannabis for Sleep: Good and Bad News

Cannabis Research Sleep

Cannabis for Sleep: Good and Bad News

May 26, 2026by Chris Aiken, MD1